# Revitope Oncology, Inc. — Form D

Revitope Oncology, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-19. The offering totals $5.2M, of which $5.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-02-19
- Form: D
- Accession: 0001140361-16-054109
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.2M
- Amount sold: $5.2M
- Investors: 12
- Date of first sale: 2016-02-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-257799

## Issuer

- Name: Revitope Oncology, Inc.
- CIK: 0001667518
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 953 Indiana St, SAN FRANCISCO, CA, 94107
- Phone: (415) 710-6702

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Raj Mehta | Director | Greenwich, CT |
| Andrew Allen | Director | Atlanta, GA |
| Andrew Allen | Executive Officer | Atlanta, GA |
| Mark Cobbold | Director | Pembroke, MA |
| Julie Cherrington | Director | San Francisco, CA |
| Julie Cherrington | Executive Officer | San Francisco, CA |
| Peter Joost | Director | San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-09-14](https://search.stillhousedata.com/formd/0001140361-16-079736) | D/A | $8.2M | $8.2M |

## More

- [CIK 1667518 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1667518&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-16-054109.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.